Global Biotechnology Insights
Dec 19, 2019
Plant-Based Meat: An Outlook For 2020
2019 has been a big year for plant-based meat substitutes. Spurred on by consumer perceptions of healthiness and a global megatrend towards conscious consumptions, sales of plant-based meat grew by almost 40%, compared with 2017. In the three months after going public, plant-based burger maker Beyond Meat's share price surged by 500% and rival Impossible Foods secured an additional $300 million in funding.
Global Biotechnology Insights
Dec 17, 2019
What Will Happen to the Cultured Meat Industry in 2020?
Will the hamburgers of the future be made from animal cells grown in a lab instead of inside a cow? Cultured meat, also known as "cell-based" or "clean" meat, could soon be making its way to our dinner plates, completely bypassing the need for animal slaughter and overcoming some of the major environmental issues that currently plague the global agriculture industry. Even though no products have yet been released and there are major challenges with cost, regulation and scale up, the industry is growing rapidly, with investment reaching a new high in 2019.
Global Biotechnology Insights
Dec 16, 2019
Webinar Thurs 16 January 2020- Innovations in Cardiovascular Disease
IDTechEx is hosting a free webinar on Thursday 16 January 2020 titled Innovations in Cardiovascular Disease Management.
Global Biotechnology Insights
Dec 19, 2019
Plant-Based Meat: An Outlook For 2020
2019 has been a big year for plant-based meat substitutes. Spurred on by consumer perceptions of healthiness and a global megatrend towards conscious consumptions, sales of plant-based meat grew by almost 40%, compared with 2017. In the three months after going public, plant-based burger maker Beyond Meat's share price surged by 500% and rival Impossible Foods secured an additional $300 million in funding.
Global Biotechnology Insights
Dec 16, 2019
Webinar Thurs 16 January 2020- Innovations in Cardiovascular Disease
IDTechEx is hosting a free webinar on Thursday 16 January 2020 titled Innovations in Cardiovascular Disease Management.